drug manufacturing

Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub
Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub
Endpoints
China
Shanghai
Boehringer Ingelheim
drug manufacturing
Flag link:
Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies
Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies
Fierce Pharma
Novartis
Lutathera
radiotherapy
drug manufacturing
Flag link:
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate
Pharmaceutical Business Review
Moderna Therapeutics
Catalent
drug manufacturing
vaccines
COVID-19
pandemic
mRNA-1273
Flag link:
Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines
Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines
Reuters
vaccines
drug manufacturing
COVID-19
CEPI
Flag link:
FDA lifts partial hold on cancer drug after Innate resolves manufacturing issue
FDA lifts partial hold on cancer drug after Innate resolves manufacturing issue
Endpoints
Innate Pharma
lacutamab
clinical trials
drug manufacturing
Flag link:
FDA warns Takeda over aseptic processing, inadequate investigations
FDA warns Takeda over aseptic processing, inadequate investigations
RAPS.org
FDA
Takeda
drug manufacturing
Flag link:
Sanofi pumps $554M into new vaccine manufacturing facility in eastern France
Sanofi pumps $554M into new vaccine manufacturing facility in eastern France
Fierce Pharma
Sanofi
vaccines
drug manufacturing
France
Flag link:
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online
Fierce Pharma
Gilead Sciences
CAR-T
Yescarta
Amsterdam
drug manufacturing
Flag link:
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine
Fierce Pharma
AstraZeneca
Emergent BioSolutions
COVID-19
vaccines
drug manufacturing
University of Oxford
Flag link:
US invests in drug vials to support coronavirus vaccine push
US invests in drug vials to support coronavirus vaccine push
BioPharma Dive
vials
drug manufacturing
federal government
vaccines
COVID-19
pandemic
Flag link:
Fujifilm doubles down on ex-Biogen facility with $928M infusion as biotech boom fuels CDMO growth
Fujifilm doubles down on ex-Biogen facility with $928M infusion as biotech boom fuels CDMO growth
Endpoints
Fujifilm
CDMO
drug manufacturing
Denmark
biologics
Flag link:
Pfizer continues recalls of menopause drug Duavee on faulty packaging concerns
Pfizer continues recalls of menopause drug Duavee on faulty packaging concerns
Fierce Pharma
drug manufacturing
Duavee
Pfizer
product recalls
Duavive
UK
Flag link:
Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine
Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine
Fierce Pharma
AstraZeneca
Oxford BioMedica
vaccines
drug manufacturing
COVID-19
CDMOs
Flag link:
As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort
As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort
Fierce Pharma
drug manufacturing
Paratek
pandemic
COVID-19
antibiotics
Flag link:
Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO
Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO
Endpoints
Lonza
Pharma CEOs
Roche
Pierre-Alain Ruffieux
drug manufacturing
Flag link:
U.S. seeks to 'onshore' drug production in response to COVID-19. Is pharma even interested?
U.S. seeks to 'onshore' drug production in response to COVID-19. Is pharma even interested?
Fierce Pharma
COVID-19
drug manufacturing
Flag link:
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners
Fierce Pharma
GSK
vaccines
COVID-19
drug manufacturing
Sanofi
pandemic
Flag link:
AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal
AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal
Fierce Pharma
AstraZeneca
University of Oxford
vaccines
COVID-19
pandemic
drug manufacturing
Flag link:
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity
Motley Fool
Novavax
vaccines
drug manufacturing
M&A
COVID-19
Praha Vaccines
Flag link:
9 ways Covid-19 may forever upend the U.S. health care industry
9 ways Covid-19 may forever upend the U.S. health care industry
Stat
COVID-19
pandemic
insurance
telemedicine
nursing homes
racial disparity
drug pricing
drug manufacturing
Flag link:

Pages